TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Barron, David A ^a   Strand, Douglas W ^b   Ressler, Steven J ^a   Dang, Truong D ^a   Hayward, Simon W ^b   Yang, Feng ^a   Ayala, Gustavo E ^a   Ittmann, Michael ^a   Rowley, David R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; PRIMER DNA;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BONE MARROW CELL; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARASYMPATHETIC GANGLION; PHENOTYPIC VARIATION; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; STROMA; VASCULAR FIBROSIS; AGING; ANIMAL; GANGLION; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNERVATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROSTATE; TRANSGENIC MOUSE; TUMOR CELL LINE;

MURINAE; MUS MUSCULUS;

AGING; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; GANGLIA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; PROSTATE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 78149461997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013751     Document Type: Article

References (28)

1. Desmouliere A, Chaponnier C, Gabbiani G (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13: 7-12.
2. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503.
3. Tuxhorn JA, Ayala GE, Rowley DR (2001) Reactive stroma in prostate cancer progression. J Urol 166: 2472-2483.
4. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, et al. (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8: 2912-2923.
5. Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD, Rowley DR (2008) Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 72: 205-213.
6. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR (2002) Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62: 3298-3307.
7. McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, et al. (2003) Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res 63: 5859-5865.
8. Schauer IG, Ressler SJ, Rowley DR (2009) Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate 69: 373-384.
9. Ao M, Franco OE, Park D, Raman D, Williams K, et al. (2007) Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67: 4244-4253.
10. Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, et al. (2009) A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci U S A 106: 2859-2863.
11. Shoskes DA, Albakri Q, Thomas K, Cook D (2002) Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 168: 331-335.
12. Gann PH, Klein KG, Chatterton RT, Ellman AE, Grayhack JT, et al. (1999) Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates. Prostate 40: 248-255.
13. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, et al. (1996) Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74: 991-1003.
14. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, et al. (1995) Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92: 2572-2576.
15. Hall BE, Zheng C, Swaim WD, Cho A, Nagineni CN, et al. (2010) Conditional over expression of TGF-beta1 disrupts mouse salivary gland development and function. Lab Invest 90: 543-555.
16. Sanvito F, Nichols A, Herrera PL, Huarte J, Wohlwend A, et al. (1995) TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes. Biochem Biophys Res Commun 217: 1279-1286.
17. Pierce DF, Jr., Gorska AE, Chytil A, Meise KS, Page DL, et al. (1995) Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A 92: 4254-4258.
18. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR (2002) Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 62: 6021-6025.
19. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, et al. (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895.
20. Zhang J, Thomas TZ, Kasper S, Matusik RJ (2000) A small composite probasin promoter confers high levels of prostate- specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 141: 4698-4710.
21. Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, et al. (2007) Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12: 559-571.
22. Wolfraim LA, Alkemade GM, Alex B, Sharpe S, Parks WT, et al. (2002) Development and application of fully functional epitope-tagged forms of transforming growth factor-beta. J Immunol Methods 266: 7-18.
23. Yang F, Strand DW, Rowley DR (2008) Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Oncogene 27: 450-459.
24. Jiang M, Strand DW, Fernandez S, He Y, Yi Y, et al. (2010) Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells 28: 344-356.
25. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, et al. (2003) Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res 9: 4792-4801.
26. Yang G, Timme TL, Park SH, Thompson TC (1997) Transforming growth factor beta 1 transduced mouse prostate reconstitutions: I. Induction of neuronal phenotypes. Prostate 33: 151-156.
27. Epstein JI (2004) Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod Pathol 17: 307-315.
28. Massague J (1999) Wounding Smad. Nat Cell Biol 1: E117-119.